• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LARVA:非编码注释中复发性变异大规模分析的综合框架。

LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.

作者信息

Lochovsky Lucas, Zhang Jing, Fu Yao, Khurana Ekta, Gerstein Mark

机构信息

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.

Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York 10065.

出版信息

Nucleic Acids Res. 2015 Sep 30;43(17):8123-34. doi: 10.1093/nar/gkv803. Epub 2015 Aug 24.

DOI:10.1093/nar/gkv803
PMID:26304545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4787796/
Abstract

In cancer research, background models for mutation rates have been extensively calibrated in coding regions, leading to the identification of many driver genes, recurrently mutated more than expected. Noncoding regions are also associated with disease; however, background models for them have not been investigated in as much detail. This is partially due to limited noncoding functional annotation. Also, great mutation heterogeneity and potential correlations between neighboring sites give rise to substantial overdispersion in mutation count, resulting in problematic background rate estimation. Here, we address these issues with a new computational framework called LARVA. It integrates variants with a comprehensive set of noncoding functional elements, modeling the mutation counts of the elements with a β-binomial distribution to handle overdispersion. LARVA, moreover, uses regional genomic features such as replication timing to better estimate local mutation rates and mutational hotspots. We demonstrate LARVA's effectiveness on 760 whole-genome tumor sequences, showing that it identifies well-known noncoding drivers, such as mutations in the TERT promoter. Furthermore, LARVA highlights several novel highly mutated regulatory sites that could potentially be noncoding drivers. We make LARVA available as a software tool and release our highly mutated annotations as an online resource (larva.gersteinlab.org).

摘要

在癌症研究中,突变率的背景模型已在编码区得到广泛校准,从而识别出许多驱动基因,其突变频率反复高于预期。非编码区也与疾病相关;然而,针对它们的背景模型尚未得到如此详细的研究。部分原因是有限的非编码功能注释。此外,巨大的突变异质性以及相邻位点之间的潜在相关性导致突变计数出现大量过度离散,从而导致背景率估计存在问题。在此,我们使用一种名为LARVA的新计算框架来解决这些问题。它将变异与一套全面的非编码功能元件整合在一起,用β-二项分布对元件的突变计数进行建模以处理过度离散。此外,LARVA利用诸如复制时间等区域基因组特征来更好地估计局部突变率和突变热点。我们在760个全基因组肿瘤序列上证明了LARVA的有效性,表明它能识别出众所周知的非编码驱动因素,如TERT启动子中的突变。此外,LARVA突出了几个新的高度突变的调控位点,这些位点可能是潜在的非编码驱动因素。我们将LARVA作为一个软件工具提供,并将我们的高度突变注释作为在线资源发布(larva.gersteinlab.org)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/586fd371496e/gkv803fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/4ca492d0f489/gkv803fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/3e9e26425f19/gkv803fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/866474ef5cd2/gkv803fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/d2ea2b0a8a9f/gkv803fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/1bed9ea53806/gkv803fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/a78e4e195647/gkv803fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/586fd371496e/gkv803fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/4ca492d0f489/gkv803fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/3e9e26425f19/gkv803fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/866474ef5cd2/gkv803fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/d2ea2b0a8a9f/gkv803fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/1bed9ea53806/gkv803fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/a78e4e195647/gkv803fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/4787796/586fd371496e/gkv803fig7.jpg

相似文献

1
LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.LARVA:非编码注释中复发性变异大规模分析的综合框架。
Nucleic Acids Res. 2015 Sep 30;43(17):8123-34. doi: 10.1093/nar/gkv803. Epub 2015 Aug 24.
2
NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.NIMBus:一种基于负二项回归的突变负担分析综合方法。
BMC Bioinformatics. 2020 Oct 22;21(1):474. doi: 10.1186/s12859-020-03758-1.
3
Identification of coding and non-coding mutational hotspots in cancer genomes.癌症基因组中编码和非编码突变热点的鉴定。
BMC Genomics. 2017 Jan 5;18(1):17. doi: 10.1186/s12864-016-3420-9.
4
MOAT: efficient detection of highly mutated regions with the Mutations Overburdening Annotations Tool.MOAT:使用突变负担注释工具高效检测高度突变区域。
Bioinformatics. 2018 Mar 15;34(6):1031-1033. doi: 10.1093/bioinformatics/btx700.
5
Functional annotation of noncoding mutations in cancer.癌症中非编码突变的功能注释。
Life Sci Alliance. 2021 Jul 19;4(9). doi: 10.26508/lsa.201900523. Print 2021 Sep.
6
IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.IW-Scoring:一种用于注释和优先排序非编码基因组中遗传变异的综合加权评分框架。
Nucleic Acids Res. 2018 May 4;46(8):e47. doi: 10.1093/nar/gky057.
7
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.肝癌全基因组突变全景及非编码区和结构突变特征。
Nat Genet. 2016 May;48(5):500-9. doi: 10.1038/ng.3547. Epub 2016 Apr 11.
8
Genome-wide analysis of noncoding regulatory mutations in cancer.癌症中非编码调控突变的全基因组分析。
Nat Genet. 2014 Nov;46(11):1160-5. doi: 10.1038/ng.3101. Epub 2014 Sep 28.
9
Using FunSeq2 for Coding and Non-Coding Variant Annotation and Prioritization.使用FunSeq2进行编码和非编码变异注释及优先级排序。
Curr Protoc Bioinformatics. 2017 May 2;57:15.11.1-15.11.17. doi: 10.1002/cpbi.23.
10
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer.FunSeq2:一种对癌症中非编码调控变异进行优先级排序的框架。
Genome Biol. 2014;15(10):480. doi: 10.1186/s13059-014-0480-5.

引用本文的文献

1
Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer.将突变异质性纳入其中,以鉴定在癌症中同义突变富集的基因。
BMC Bioinformatics. 2023 Dec 7;24(1):462. doi: 10.1186/s12859-023-05521-8.
2
Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.利用组织特异性增强子-靶基因调控网络鉴定具有功能影响肺癌的增强子体细胞突变。
Cancer Res. 2024 Jan 2;84(1):133-153. doi: 10.1158/0008-5472.CAN-23-1129.
3
Model selection and robust inference of mutational signatures using Negative Binomial non-negative matrix factorization.

本文引用的文献

1
Data for Genetic Analysis Workshop 18: human whole genome sequence, blood pressure, and simulated phenotypes in extended pedigrees.遗传分析研讨会18的数据:人类全基因组序列、血压以及扩展家系中的模拟表型。
BMC Proc. 2014 Jun 17;8(Suppl 1):S2. doi: 10.1186/1753-6561-8-S1-S2. eCollection 2014.
2
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.阻断前列腺素E2诱导的肿瘤再增殖可消除膀胱癌的化疗耐药性。
Nature. 2015 Jan 8;517(7533):209-13. doi: 10.1038/nature14034. Epub 2014 Dec 3.
3
A DNA methylation-based definition of biologically distinct breast cancer subtypes.
使用负二项式非负矩阵分解进行突变特征的模型选择和稳健推断。
BMC Bioinformatics. 2023 May 8;24(1):187. doi: 10.1186/s12859-023-05304-1.
4
Cancer driver mutations: predictions and reality.癌症驱动突变:预测与现实。
Trends Mol Med. 2023 Jul;29(7):554-566. doi: 10.1016/j.molmed.2023.03.007. Epub 2023 Apr 17.
5
Unified views on variant impact across many diseases.对多种疾病中变异影响的统一认识。
Trends Genet. 2023 Jun;39(6):442-450. doi: 10.1016/j.tig.2023.02.002. Epub 2023 Feb 28.
6
Widespread perturbation of ETS factor binding sites in cancer.癌症中 ETS 因子结合位点的广泛扰动。
Nat Commun. 2023 Feb 17;14(1):913. doi: 10.1038/s41467-023-36535-8.
7
Transcription Factor-Centric Approach to Identify Non-Recurring Putative Regulatory Drivers in Cancer.以转录因子为中心的方法来识别癌症中不常见的假定调控驱动因素。
Res Comput Mol Biol. 2022 May;13278:36-51. doi: 10.1007/978-3-031-04749-7_3. Epub 2022 Apr 29.
8
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers.顺式调控突变与癌症中基因调控程序的转录和转录后失调有关。
Nucleic Acids Res. 2022 Nov 28;50(21):12131-12148. doi: 10.1093/nar/gkac1143.
9
Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.解读胚系和体细胞非编码突变在癌症中的作用:基于表达和染色质构象的分析。
Clin Epigenetics. 2022 Sep 28;14(1):120. doi: 10.1186/s13148-022-01342-3.
10
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.比较基因组学为黑色素瘤亚型提供病因和生物学见解。
Cancer Discov. 2022 Dec 2;12(12):2856-2879. doi: 10.1158/2159-8290.CD-22-0603.
基于DNA甲基化的生物学上不同的乳腺癌亚型定义。
Mol Oncol. 2015 Mar;9(3):555-68. doi: 10.1016/j.molonc.2014.10.012. Epub 2014 Nov 5.
4
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer.复发性CYP2C19缺失等位基因与三阴性乳腺癌相关。
BMC Cancer. 2014 Dec 2;14:902. doi: 10.1186/1471-2407-14-902.
5
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.早期达拉非尼/曲美替尼联合治疗 BRAF 突变转移性黑色素瘤耐药中 MAPK 再激活增加。
Nat Commun. 2014 Dec 2;5:5694. doi: 10.1038/ncomms6694.
6
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.通过质谱分析与外显子组测序相结合预测免疫原性肿瘤突变。
Nature. 2014 Nov 27;515(7528):572-6. doi: 10.1038/nature14001.
7
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.浆液性和透明细胞子宫内膜癌中酪氨酸激酶组的突变分析揭示了TNK2和DDR1中罕见的体细胞突变。
BMC Cancer. 2014 Nov 26;14:884. doi: 10.1186/1471-2407-14-884.
8
Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.评估BRCA1和BRCA2基因的miRNA结合位点的遗传变异作为早发性和/或家族性乳腺癌发生风险因素的情况。
Asian Pac J Cancer Prev. 2014;15(19):8319-24. doi: 10.7314/apjcp.2014.15.19.8319.
9
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer.FunSeq2:一种对癌症中非编码调控变异进行优先级排序的框架。
Genome Biol. 2014;15(10):480. doi: 10.1186/s13059-014-0480-5.
10
Genome-wide analysis of noncoding regulatory mutations in cancer.癌症中非编码调控突变的全基因组分析。
Nat Genet. 2014 Nov;46(11):1160-5. doi: 10.1038/ng.3101. Epub 2014 Sep 28.